Table of Contents

 
 
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 28, 2007
CELANESE CORPORATION
(Exact Name of Registrant as specified in its charter)
         
DELAWARE   001-32410   98-0420726
         
(State or other jurisdiction
of incorporation) 		  (Commission File
Number) 		  (IRS Employer
Identification No.)
         
1601 West LBJ Freeway, Dallas, Texas       75234-6034
         
(Address of Principal Executive Offices)       (Zip Code)
Registrant’s telephone number, including area code: (972) 443-4000
Not Applicable
(Former name or former address, if changed since last report):
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 

 

TABLE OF CONTENTS

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 9.01 Financial Statements and Exhibits
SIGNATURES
Exhibit Index
EX-99.1: PRESS RELEASE

Table of Contents

Item 5.02   Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
     On June 1, 2007, Celanese Corporation (the “ Company ”) issued a press release announcing that, in connection with the sale by Blackstone Capital Partners (Cayman) Ltd. 1, Blackstone Capital Partners (Cayman) Ltd. 2, Blackstone Capital Partners (Cayman) Ltd. 3 and Blackstone Management Partners IV L.L.C. (collectively, “ Blackstone ”) of shares of the Company’s Series A common stock (as more fully described in the Current Report on Form 8-K that was filed by the Company with the Securities and Exchange Commission on May 16, 2007), Anjan Mukherjee and James Quella had resigned as members of the Company’s Board of Directors. Each of the resignations was effective May 31, 2007. A copy of the press release is attached hereto as Exhibit 99.1.
     The Company also announced that Farah M. Walters had been elected to the Company’s Board of Directors as a Class III director. The election was effective May 31, 2007.
Item 9.01   Financial Statements and Exhibits.
     (c) Exhibits
     
Exhibit Number   Description
 
   
99.1
  Press Release dated June 1, 2007

 

Table of Contents

SIGNATURES
     Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
         
  CELANESE CORPORATION
  		 
  By    /s/ Kevin J. Rogan  
    Name:   Kevin J. Rogan   
    Title:   Assistant Secretary   
 
Date: June 1, 2007

 

Table of Contents

Exhibit Index
     
Exhibit Number   Description
 
   
99.1
  Press Release dated June 1, 2007

 

 

(CELANESE LOGO)
Investor News Release
Celanese Corporation
Investor Relations
1601 West LBJ Freeway
Dallas, Texas 75234-6034
Mark Oberle
Phone: +1 972 443 4464
Fax: +1 972 332 9373
mark.oberle@celanese.com
Web site: www.celanese.com
Celanese Announces Changes to Board of Directors; Elects Walters as New Member
DALLAS, June 1, 2007 — Celanese Corporation (NYSE: CE), a global hybrid chemical company, today announced that Farah M. Walters has been elected to the Celanese board of directors. Walters is currently president and chief executive officer of QualHealth LLC, a company specializing in the design of health care delivery systems to improve quality and cost-effectiveness.
Walters also serves on the board of directors and is lead director for PolyOne Corporation, an NYSE-listed specialty chemical company. She chairs the company’s governance and compensation committees and serves on the financial policy committee.
Previously, Walters served on the board of Kerr-McGee Corporation, an NYSE-listed oil and gas exploration and production company. She served on the company’s executive committee, chaired the compensation committee and was a member of the audit and governance committees. She was also a former chair of the audit committee. Walters also previously served on the board of directors of Alpharma Inc., an NYSE-listed pharmaceutical company.
Walters was president and chief executive officer of both University Hospitals Health System, Inc. and University Hospitals of Cleveland from 1992 to 2002.

 

 

Celanese also announced that Anjan Mukherjee and James A. Quella, both with The Blackstone Group L.P., resigned from the Celanese board of directors effective May 31, 2007. Mukherjee and Quella resigned from the Celanese board of directors due to the recent public sale by funds affiliated with The Blackstone Group, L.P. of all Celanese shares owned by Blackstone and its affiliates.
About Celanese:
As a global leader in the chemicals industry, Celanese Corporation makes products essential to everyday living. Our products, found in consumer and industrial applications, are manufactured in North America, Europe and Asia. Net sales totaled $6.7 billion in 2006, with over 60% generated outside of North America. Known for operational excellence and execution of its business strategies, Celanese delivers value to customers around the globe with innovations and best-in-class technologies. Based in Dallas, Texas, the company employs approximately 8,900 employees worldwide. For more information on Celanese Corporation, please visit the company’s website at www.celanese.com .

2